1. Home
  2. TNET vs NRIX Comparison

TNET vs NRIX Comparison

Compare TNET & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriNet Group Inc.

TNET

TriNet Group Inc.

HOLD

Current Price

$37.06

Market Cap

1.7B

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$15.06

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNET
NRIX
Founded
1988
2009
Country
United States
United States
Employees
2700
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
TNET
NRIX
Price
$37.06
$15.06
Analyst Decision
Hold
Strong Buy
Analyst Count
5
12
Target Price
$65.80
$30.58
AVG Volume (30 Days)
518.7K
762.0K
Earning Date
04-24-2026
04-07-2026
Dividend Yield
2.94%
N/A
EPS Growth
N/A
N/A
EPS
3.20
N/A
Revenue
$5,010,000,000.00
$76,987,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.30
$26.32
P/E Ratio
$11.69
N/A
Revenue Growth
N/A
99.31
52 Week Low
$33.67
$8.18
52 Week High
$88.56
$22.50

Technical Indicators

Market Signals
Indicator
TNET
NRIX
Relative Strength Index (RSI) 37.49 41.24
Support Level $33.67 $14.91
Resistance Level $39.10 $16.47
Average True Range (ATR) 1.62 0.81
MACD 0.82 0.02
Stochastic Oscillator 48.33 25.34

Price Performance

Historical Comparison
TNET
NRIX

About TNET TriNet Group Inc.

Trinet Group Inc provides human resources solutions for small and medium-sized businesses through technology-enabled services. Its offerings include human capital expertise, employee benefits such as health insurance and retirement plans, payroll and payroll tax administration, risk mitigation, and compliance consulting. The company provides its services through professional employer organization (PEO) services delivered via a co-employment model, as well as administrative services organization (ASO) offerings. The majority of the company's revenue is derived from the insurance-related billings and administrative fees collected from PEO clients.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: